查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1882163

全球鼻腔給藥市場

Intranasal Drug Delivery
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 320 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球鼻腔給藥市場預計到2030年將達到933億美元

全球鼻腔給藥市場預計在2024年達到631億美元，預計到2030年將達到933億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為6.7%。本報告分析的細分市場之一－液體給藥裝置，預計複合年成長率為6.3%，到分析期末將達到382億美元。粉末給藥裝置細分市場預計在分析期間內複合年成長率為7.6%。

美國市場規模估計為262億美元，而中國市場預計將以9.1%的複合年成長率成長。

預計到2024年，美國鼻腔給藥市場規模將達262億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到82億美元，在2024年至2030年的分析期間內，年複合成長率（CAGR）將達到9.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的年複合成長率將分別達到5.2%和5.5%。在歐洲，德國的年複合成長率預計將達到約6.4%。

全球鼻腔給藥市場－主要趨勢與促進因素摘要

鼻腔給藥是指經由鼻腔給藥，這是一種非侵入性且高效的藥物吸收途徑。此方法利用鼻粘膜豐富的血管和較大的表面積，與其他非侵入性給藥途徑相比，起效更快，生物利用度更高。鼻腔給藥系統可用於多種藥物，包括疼痛管理、神經系統疾病治療和疫苗接種。這些系統的基礎技術包括定量滴鼻劑、鼻凝膠和粉末，每種製劑都旨在最佳化藥物吸收並最大限度地減少全身副作用。

鼻腔給藥已成為現代醫學中一種用途廣泛的工具，其應用涵蓋多個治療領域。在需要快速起效的緊急情況下，例如使用納洛酮治療鴉片類藥物過量或使用腎上腺素治療過敏反應，鼻腔給藥尤其重要。此外，鼻腔給藥作為一種便捷、非侵入性的注射替代療法，也擴大用於治療慢性疾病，例如偏頭痛和荷爾蒙療法。而且，鼻腔給藥能夠繞過胃腸道和肝臟的首過代謝，因此對於吸收不良或代謝顯著的藥物而言，鼻腔給藥是一種理想的給藥途徑。

鼻腔給藥市場的成長受多種因素驅動，包括給藥技術的進步、需要快速介入的急性和慢性疾病的增加，以及病患和醫護人員對非侵入性給藥方式日益成長的偏好。技術創新，例如改進的製劑和新型給藥裝置，正在提高藥物的穩定性和吸收率，從而擴大可治療疾病的範圍。此外，人口老化以及阿茲海默症和帕金森氏症等疾病發病率的上升等人口趨勢，也推動了對更有效給藥系統的需求。消費行為向自我給藥和居家醫療的轉變，以及醫療成本控制措施，進一步促進了市場擴張。經鼻吸入型疫苗的研發，尤其是在新冠肺炎疫情期間，凸顯了這種給藥方式在全球衛生策略中的重要角色。

部分：

產品類型（液體輸送裝置、粉末輸送裝置、壓力定量吸入器、其他產品類型）、應用領域（呼吸系統、神經系統、疼痛管理、其他應用領域）

受訪公司範例

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T;Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP-1795

Global Intranasal Drug Delivery Market to Reach US$93.3 Billion by 2030

The global market for Intranasal Drug Delivery estimated at US$63.1 Billion in the year 2024, is expected to reach US$93.3 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$38.2 Billion by the end of the analysis period. Growth in the Powder Delivery Devices segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$26.2 Billion While China is Forecast to Grow at 9.1% CAGR

The Intranasal Drug Delivery market in the U.S. is estimated at US$26.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$8.2 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Intranasal Drug Delivery Market - Key Trends and Drivers Summarized

Intranasal drug delivery refers to the administration of medications through the nasal cavity, offering a non-invasive and efficient route for drug absorption. This method leverages the rich vascularization and large surface area of the nasal mucosa, enabling rapid onset of action and enhanced bioavailability compared to other non-invasive routes. Intranasal delivery systems are utilized for a variety of drugs, including those for pain management, neurological disorders, and vaccinations. The technology behind these systems includes metered-dose nasal sprays, nasal gels, and powder formulations, each designed to optimize drug absorption and minimize systemic side effects.

The application of intranasal drug delivery spans several therapeutic areas, making it a versatile tool in modern medicine. It is particularly beneficial in emergency situations where rapid drug action is critical, such as with naloxone for opioid overdoses or epinephrine for anaphylactic reactions. Additionally, intranasal delivery is increasingly used for chronic conditions like migraines and hormonal therapies, where it offers a convenient and non-invasive alternative to injections. The ability to bypass the gastrointestinal tract and first-pass metabolism in the liver also makes this route advantageous for drugs that are poorly absorbed orally or extensively metabolized.

The growth in the intranasal drug delivery market is driven by several factors, including advancements in delivery technologies, increasing prevalence of chronic and acute conditions requiring rapid intervention, and a growing preference for non-invasive administration methods among patients and healthcare providers. Technological innovations, such as improved formulations and novel delivery devices, enhance drug stability and absorption, expanding the range of treatable conditions. Additionally, demographic trends such as aging populations and rising incidences of conditions like Alzheimer's disease and Parkinson's disease fuel demand for more effective drug delivery systems. Consumer behavior shifts towards self-administration and home care, coupled with healthcare cost containment strategies, further propel market expansion. The development of intranasal vaccines, particularly highlighted by the COVID-19 pandemic, also underscores the critical role of this delivery method in global health strategies.

SCOPE OF STUDY:

The report analyzes the Intranasal Drug Delivery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers, Other Product Types); Application (Respiratory Disorders, Neurological Disorders, Pain Management, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 77 Featured) -

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Intranasal Drug Delivery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Intranasal Drug Delivery: A Prelude
    • Leading Indications and APIs Amenable to Nasal Drug Delivery
    • Regional Market Analysis
    • Why Nasal Application is Garnering Notable Attention for Drug Delivery
    • Limitations of Intranasal Drug Delivery
    • Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range
    • Drug Delivery Pathways Related to the Nasal Cavity
    • Systemic delivery and Local Delivery Routes
    • Differences between Systemic Delivery and Local Effects
    • Challenges Involved In Formulating Nasal Drugs
    • Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
    • Nose-to-Brain Drug Delivery: An Evolving Area of Interest
    • Factors Inhibiting Nose-to-Brain Transportation of Drugs
    • Bioavailability: An Important Facet of Intranasal Drug Delivery
    • Traditional Vs. Advanced Intranasal Drug Formulation Types
    • Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application
    • Select FDA-Approved Nasal Products Compound (Trade Name) Indication Dosage Form Year
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Prevalence of COPD Drives Opportunities
    • Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
    • Pharmaceutical and Medical Device Companies Vie to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
    • Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
    • The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
    • The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
    • Intranasal Corticosteroids : A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
    • Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage
    • Manufacturers Focus on Improved Nasal Delivery Platforms
    • Controlled Release Technology is the Buzz Word
    • Research on Nanocarrier-Based Intranasal Drug Delivery Systems Picks Up Pace
    • Potential Role in Treatment and Management of Coronavirus Infection
    • Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
    • Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
    • Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
    • Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
    • Intranasal Therapeutics Delivery: A High Potential Method for Treating CNS Diseases
    • Researchers Develop Nasal Spray Treatment for Parkinson's Disease
    • Future Opportunities in CNS Space
    • Intranasal Delivery of Stem Cells: A Primary Strategy for Treatment of CNS Disorders
    • Intranasal Delivery of Stem Cells: Limitations
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Intranasal Delivery of Peptide-Based Pharmaceuticals
    • Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace
    • Select List of Nasal Biologics Available in the Market
    • Benefits of Bi-Directional Nasal Drug Delivery
    • Rise in Interest in Preservative-free Nasal Spray Formulations
    • Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 3: World 14-Year Perspective for Liquid Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 6: World 14-Year Perspective for Powder Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 9: World 14-Year Perspective for Pressurized Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 12: World 14-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 15: World 14-Year Perspective for Respiratory Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 18: World 14-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 21: World 14-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 24: World 14-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2025 & 2030
    • TABLE 25: World Intranasal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2016 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 28: World 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 31: USA 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 34: USA 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 37: Canada 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 40: Canada 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • JAPAN
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 43: Japan 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 46: Japan 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • CHINA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 49: China 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 52: China 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • EUROPE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 55: Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 58: Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 61: Europe 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2025 & 2030
  • FRANCE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 64: France 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 67: France 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • GERMANY
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 70: Germany 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 73: Germany 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 76: Italy 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 79: Italy 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • UNITED KINGDOM
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 82: UK 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 85: UK 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 88: Spain 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 91: Spain 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 94: Russia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 97: Russia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • ASIA-PACIFIC
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2025 & 2030
  • AUSTRALIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 115: Australia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 118: Australia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • INDIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 121: India 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 124: India 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 127: South Korea 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 130: South Korea 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • LATIN AMERICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 139: Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 142: Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 145: Latin America 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 148: Argentina 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 151: Argentina 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 154: Brazil 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 157: Brazil 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 160: Mexico 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 163: Mexico 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • MIDDLE EAST
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 172: Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 175: Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 178: Middle East 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 181: Iran 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 184: Iran 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 187: Israel 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 190: Israel 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 199: UAE 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 202: UAE 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030
  • AFRICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 211: Africa 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2023 and % CAGR
    • TABLE 214: Africa 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2025 & 2030

IV. COMPETITION